MarvelBiome Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $39.6M

  • Investors
  • 3

MarvelBiome General Information

Description

Developer of microbiome-based therapeutics designed to treat human diseases. The company offers microbial population isolation, bacterial genetic characterization, therapeutic assay development, microbiome-based drug discovery, clinical trial implementation, and molecular biology research, enabling healthcare providers to access novel therapeutic options derived from characterized microbial populations for disease treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8 Cabot Road
  • Suite 3500
  • Woburn, MA 01801
  • United States
+1 (978)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 8 Cabot Road
  • Suite 3500
  • Woburn, MA 01801
  • United States
+1 (978)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MarvelBiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 22-Oct-2025 $39.6M Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Early Stage VC (Series B) 17-Nov-2020 $3.1M $5.36M Completed Generating Revenue
1. Early Stage VC (Series A) 12-Jun-2020 $2.26M $2.26M Completed Generating Revenue
To view MarvelBiome’s complete valuation and funding history, request access »

MarvelBiome Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C-2
Series C-1
Series C
Series B 18,894,427 $0.000100 $1.06 $1.06 1x $1.06 17.31%
Series A 21,652,967 $0.000100 $0.1 $0.1 1x $0.1 19.83%
To view MarvelBiome’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MarvelBiome Patents

MarvelBiome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026236698-A1 The present disclosure provides compounds, pharmaceutical compositions, and methods for modulating one or more transcription factors such as ahr or nrf2 Pending 09-May-2025
JP-2026531596-A Methods and use of microbiome compositions, components or metabolites for treating diseases, disorders and conditions related to lipid and cholesterol metabolism. Pending 08-Sep-2023
WO-2025054048-A1 Methods and uses of microbiome compositions, components, or metabolites for treating lipid and cholesterol metabolism associated diseases, disorders, and conditions Inactive 08-Sep-2023
AU-2024338317-A1 Methods for treating lipid and cholesterol metabolism associated diseases and conditions Pending 08-Sep-2023
EP-4774366-A1 Methods for treating lipid and cholesterol metabolism associated diseases and conditions Pending 08-Sep-2023 A61P3/04
To view MarvelBiome’s complete patent history, request access »

MarvelBiome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MarvelBiome Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Thomvest Ventures Venture Capital Minority
DRADS Capital Venture Capital Minority
C2I Accelerator Accelerator/Incubator
To view MarvelBiome’s complete investors history, request access »

MarvelBiome FAQs

  • When was MarvelBiome founded?

    MarvelBiome was founded in 2019.

  • Where is MarvelBiome headquartered?

    MarvelBiome is headquartered in Woburn, MA.

  • What is the size of MarvelBiome?

    MarvelBiome has 14 total employees.

  • What industry is MarvelBiome in?

    MarvelBiome’s primary industry is Drug Discovery.

  • Is MarvelBiome a private or public company?

    MarvelBiome is a Private company.

  • What is the current valuation of MarvelBiome?

    The current valuation of MarvelBiome is .

  • What is MarvelBiome’s current revenue?

    The current revenue for MarvelBiome is .

  • How much funding has MarvelBiome raised over time?

    MarvelBiome has raised $44.9M.

  • Who are MarvelBiome’s investors?

    Thomvest Ventures, DRADS Capital, and C2I Accelerator have invested in MarvelBiome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process